Cryo-Cell International Inc.

CCEL Healthcare Medical Care Facilities

Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024.

Revenue
−0.02%
EPS
+77.8%
Free cash flow
−58.4%
Total debt
−29.5%

Quarter to August 2026, against a year earlier

4.97 0.02 +0.40%
Market cap
$39.9M
P/E
0.0×
Fwd P/E
65.1×
Dividend yield
0.00%
F-score
6/9
Altman Z
−0.23
Beneish M
−3.17
Dividend safety
20/100
Nov '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 Nov '17 Nov '16
P/E ratio
0.00 170.80 0.00 12.85 47.62 15.96 26.32 0.00 24.42 0.00
Piotroski F-Score
6 9 6 5 4 8 6 3 7 4
P/S ratio
1.02 2.17 1.42 1.22 3.49 1.82 1.85 1.87 2.24 1.49
Altman Z-Score
(0.23) 0.34 (0.72) 0.36 1.27 1.40 1.11 0.88 1.20 (0.32)
Altman Z″-Score (non-manufacturers)
(3.07) (2.39) (4.39) (1.69) (0.95) 0.03 (1.07) (1.41) (2.62) (6.16)
P/FCF ratio
8.24 32.44 34.84 0.00 103.33 7.06 10.83 11.66 10.13 7.42
Beneish M-Score
(3.17) (2.75) (3.90) (2.70) (2.97) (2.94) (2.80) (2.72) (2.68) (4.04)
P/Operating CF
25.07 32.19 13.34 15.23 60.41 19.01 52.34 64.73 26.96 13.45
Dividend Safety Score
20 — — — — — — — — —
P/B ratio
0.00 0.00 0.00 0.00 24.07 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.24 2.43 1.70 1.52 3.30 1.68 1.80 1.97 2.19 1.65
EV/EBITDA
20.99 17.19 0.00 7.89 17.63 6.24 10.27 10.25 10.35 13.84
EV/FCF
10.08 36.33 41.61 (6.86) 97.67 6.53 10.54 12.28 9.88 8.22
Current Ratio
0.59 0.58 0.45 0.49 0.75 1.13 1.00 0.96 0.91 0.69
Net Debt/EBITDA
3.83 1.84 (0.82) 1.56 (1.02) (0.50) 0.27 1.07 0.11 2.07
Debt/Equity
(0.56) (0.90) (0.87) (7.12) 0.67 (2.33) (1.29) (1.45) (0.58) (0.64)
ROE
15.27% (3.32%) 151.67% 208.38% 274.29% (75.37%) (28.89%) 7.98% (16.59%) 12.96%
ROA
(3.84%) 0.64% (15.10%) 4.41% 3.90% 8.14% 5.37% (2.58%) 10.66% (6.77%)
ROIC
0.00% 0.00% 0.00% 33.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(18.69%) 3.13% (99.33%) 74.26% (101.10%) 95.83% 126.94% (103.79%) (722.11%) 42.33%
Average Days of Receivables
79.16 83.41 76.58 72.72 66.38 74.10 69.95 73.29 73.70 63.96
Earnings Yield
(7.79%) 0.59% (21.31%) 7.78% 2.10% 6.27% 3.80% (1.91%) 4.09% (4.79%)
Free Cash Flow Yield
12.13% 3.08% 2.87% (18.18%) 0.97% 14.17% 9.23% 8.58% 9.87% 13.47%
Free Cash Flow per Share
0.66 0.30 0.15 (0.79) 0.12 1.06 0.72 0.63 0.80 0.57
Book value per Share
(2.31) (1.63) (1.32) (0.18) 0.51 (0.35) (0.89) (1.19) (1.77) (1.90)
Free Cash Flow
5.36 2.41 1.28 (6.73) 0.97 8.02 5.63 4.69 5.62 4.65
EV/EBIT
81.46 22.35 0.00 11.46 23.70 6.83 11.31 11.09 11.09 88.04
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026